Nyxoah SA Ordinary Shares NYXH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NYXH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $11.29
- Day Range
- $9.76–11.00
- 52-Week Range
- $4.00–20.00
- Bid/Ask
- $9.78 / $10.70
- Market Cap
- $304.61 Mil
- Volume/Avg
- 170 / 49,044
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 62.30
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 147
- Website
- https://www.nyxoah.com
Comparables
Valuation
|
Metric
|
NYXH
|
TCMD
|
NARI
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 26.22 | 409.01 |
Price/Book Value | 3.01 | 1.74 | 4.73 |
Price/Sales | 62.30 | 1.21 | 4.38 |
Price/Cash Flow | — | 15.97 | 64.92 |
Price/Earnings
NYXH
TCMD
NARI
Financial Strength
|
Metric
|
NYXH
|
TCMD
|
NARI
|
|---|---|---|---|
Quick Ratio | 4.41 | 2.88 | 2.43 |
Current Ratio | 4.73 | 3.54 | 3.09 |
Interest Coverage | −216.64 | — | −56.99 |
Quick Ratio
NYXH
TCMD
NARI
Profitability
|
Metric
|
NYXH
|
TCMD
|
NARI
|
|---|---|---|---|
Return on Assets (Normalized) | −29.31% | 10.70% | 5.07% |
Return on Equity (Normalized) | −38.39% | 18.16% | 6.37% |
Return on Invested Capital (Normalized) | −34.27% | 12.90% | 3.35% |
Return on Assets
NYXH
TCMD
NARI
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Nwxnpdlrg | Jmj | $133.1 Bil | |
BDX
| Becton Dickinson & Co | Vbcrvrslm | Dqpdbv | $66.9 Bil | |
ALC
| Alcon Inc | Qvycmvyzf | Ktpmq | $38.9 Bil | |
RMD
| ResMed Inc | Vdknbstxd | Txykxp | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Zpcbndwmr | Spq | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Nmksqqjq | Qwcq | $26.4 Bil | |
BAX
| Baxter International Inc | Jvnsyldh | Bzzsmpq | $20.4 Bil | |
HOLX
| Hologic Inc | Jqnntpd | Dzqbmj | $17.8 Bil | |
COO
| The Cooper Companies Inc | Rpngtsqs | Mqckdtx | $17.7 Bil | |
TFX
| Teleflex Inc | Ymwnc | Hpwj | $9.7 Bil |